Evidence map›Paper›PMID 27298342›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Identification of S-phase DNA damage-response targets in fission yeast reveals conservation of damage-response networks.

Nicholas A Willis, Chunshui Zhou, Andrew E H Elia, Johanne M Murray, Antony M Carr, Stephen J Elledge, Nicholas Rhind

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Nicholas A WillisDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605;
Chunshui ZhouDepartment of Genetics, Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; The Laboratory of Medical Genetics, Harbin Medical University, Harbin, China, 150081;
Andrew E H EliaDepartment of Genetics, Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114;
Johanne M MurrayGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, BN1 9RQ, United Kingdom;
Antony M CarrGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, BN1 9RQ, United Kingdom;
Stephen J ElledgeDepartment of Genetics, Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115 selledge@genetics.med.harvard.edu nick.rhind@umassmed.edu.
Nicholas RhindDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605; selledge@genetics.med.harvard.edu nick.rhind@umassmed.edu.
Harvard University · USUniversity of Massachusetts Chan Medical School · USUniversity of Sussex · GBHarbin Medical University · CN

Funding

Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical OncologyK12CA087723 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Tsai Ting · 2002 to 2026
$17.9M
Ubiquitin Mediated Proteolysis and Cell Cycle ControlR01AG011085 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JEFFREY W HARPER · 1993 to 2026
$10.9M
Genetics of Cell Cycle &DNA Damage Regulation in YeastR37GM044664 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ELLEDGE, STEPHEN J · 2003 to 2012
$3.5M
GENETICS OF CELL CYCLE &DNA DAMAGE REGULATION IN YEASTR01GM044664 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ELLEDGE, STEPHEN J · 1990 to 2016
$2.0M
The Regulation of DNA Replication KineticsR01GM098815 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RHIND, NICHOLAS R · 2012 to 2015
$1.3M
Biotechnology and Biological Sciences Research Council BB/C510291/1Medical Research Council G0901011Medical Research Council G1100074NCI NIH HHS K12 CA087723NIA NIH HHS R01 AG011085NIGMS NIH HHS R01 GM044664NIGMS NIH HHS R01 GM098815NIGMS NIH HHS R37 GM044664Worldwide Cancer Research 10-0273
6 · The paper itself

Abstract

The cellular response to DNA damage during S-phase regulates a complicated network of processes, including cell-cycle progression, gene expression, DNA replication kinetics, and DNA repair. In fission yeast, this S-phase DNA damage response (DDR) is coordinated by two protein kinases: Rad3, the ortholog of mammalian ATR, and Cds1, the ortholog of mammalian Chk2. Although several critical downstream targets of Rad3 and Cds1 have been identified, most of their presumed targets are unknown, including the targets responsible for regulating replication kinetics and coordinating replication and repair. To characterize targets of the S-phase DDR, we identified proteins phosphorylated in response to methyl methanesulfonate (MMS)-induced S-phase DNA damage in wild-type, rad3∆, and cds1∆ cells by proteome-wide mass spectrometry. We found a broad range of S-phase-specific DDR targets involved in gene expression, stress response, regulation of mitosis and cytokinesis, and DNA replication and repair. These targets are highly enriched for proteins required for viability in response to MMS, indicating their biological significance. Furthermore, the regulation of these proteins is similar in fission and budding yeast, across 300 My of evolution, demonstrating a deep conservation of S-phase DDR targets and suggesting that these targets may be critical for maintaining genome stability in response to S-phase DNA damage across eukaryotes.

Indexed as

DNA DamageS PhaseCheckpoint Kinase 2Gene Expression Regulation, FungalGenomic InstabilityMethyl MethanesulfonateSchizosaccharomycesSchizosaccharomyces pombe ProteinsCds1 protein, S pombeCheckpoint Kinase 2Methyl Methanesulfonaterad3 protein, S pombeSchizosaccharomyces pombe ProteinsCds1checkpointDDRDNA damageRad3

Identifiers

PMID27298342
PMCPMC4932944
OpenAlexW2432996635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.